CXCR4 and neoplasm: Inhibit the HIF1α/SDF1α-CXCR4/PI3K-AKT signaling pathway to reduce vascular endothelial growth factor synthesis and release, decrease type IV collagen degradation, and suppress tumor growth and liver metastasis in nude mice